Back

Microvascular endothelial function predicts incident diabetes mellitus: the ELSA-Brasil cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic diseases (2) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Luisa C C Brant

Federal University of Minas Gerais, Belo Horizonte (Brazil)

5 More presentations in this session

Presentation thumbnail
The underestimated risk of prediabetes on cardiovascular and renal outcomes in patients with heart failure
Doctor A. Hammer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
The Relationship Between High-Sensitivity CRP and Cardiac Function in Patients with Type 2 Diabetes: A Cardiac Magnetic Resonance Study
Doctor A. Bojer (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and mortality: an AI-CVD study
Doctor M. Naghavi (Houston, US)
Abstract Slides Video
Presentation thumbnail
Inflammatory biomarkers suPAR, IL-6, and hsCRP and 13-year risk of mortality and MACE in type 2 diabetes: a prospective cohort study
Doctor H. Bahrami (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Time for cardiologists to focus on prediabetes: challenges in risk factor control
Assistant Professor V. Medovchshikov (Aktobe, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiometabolic diseases (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Erythrocyte-derived extracellular vesicles from type 2 diabetes patients induce endothelial dysfunction through arginase 1
thumbnail
Congress Presentation
Empagliflozin significantly reduces circulating markers of endothelial dysfunction in Ischemia with Non-Obstructive Coronary Arteries (INOCA) and coronary microvascular dysfunction: a pilot trial
thumbnail
Congress Presentation
Twelve-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources